All Stories

  1. Updated guidelines by the European Society for the Study of Coeliac Disease
  2. Physician Review of a Celiac Disease Risk Estimation and Decision-Making Expert System
  3. Patient-oriented education and visual-aid intervention are inadequate to identify patients with potential capsule retention: a prospective randomized study
  4. Microbial monotherapy with Prevotella histicola for patients with multiple sclerosis
  5. Mode of delivery is not associated with celiac disease
  6. Reply
  7. Editorial: a novel approach to monitor mucosal healing in coeliac disease-as simple as shifting goalposts? Authors’ reply
  8. Undetectable negative tissue transglutaminase IgA antibodies predict mucosal healing in treated coeliac disease patients
  9. North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma
  10. Serum alkylresorcinols as biomarkers of dietary gluten exposure in coeliac disease
  11. Validation of celiac disease diagnoses recorded in the Danish National Patient Register using duodenal biopsies, celiac disease-specific antibodies, and human leukocyte-antigen genotypes
  12. Iron Deficiency in Long-Term Parenteral Nutrition Therapy
  13. Serologic microbial associated markers can predict Crohn's disease behaviour years before disease diagnosis
  14. The potential utility of tight junction regulation in celiac disease: focus on larazotide acetate
  15. Immunopathogenesis of olmesartan-associated enteropathy
  16. Update on celiac disease – etiology, differential diagnosis, drug targets, and management advances